NEXOBRID

This brand name is authorized in Austria, Croatia, Estonia, Finland, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug NEXOBRID contains one active pharmaceutical ingredient (API):

1
UNII KVZ6B40N8U - ANANAS COMOSUS WHOLE
 
Read more about

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D03BA03 D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03B Enzymes → D03BA Proteolytic enzymes
Discover more medicines within D03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1603583, 1603594
ES Centro de información online de medicamentos de la AEMPS 112803001, 112803002
FI Lääkealan turvallisuus- ja kehittämiskeskus 172192
GB Medicines & Healthcare Products Regulatory Agency 335155, 368656
IL מִשְׂרַד הַבְּרִיאוּת 8711, 8712
IT Agenzia del Farmaco 042539015, 042539027
JP 医薬品医療機器総合機構 26997A5Q1025
LT Valstybinė vaistų kontrolės tarnyba 1068856, 1068857
PL Rejestru Produktów Leczniczych 100069129, 100295794
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W61294001, W61476001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.